{"podcast":{"title":"Breast Cancer Update","slug":"breast-cancer-update-757579","podcast_index_feed_id":757579,"rss_url":"https://feeds.captivate.fm/breast-oncology/","website_url":"https://www.researchtopractice.com/browse-by-tumor-types/breast-cancer","image_url":"https://artwork.captivate.fm/ad97e2be-455a-4b53-ab3d-383838c145e5/cbjJP3tyd5NWFP4W5DD1CnhC.png","author":"Dr. Neil Love","episode_count":100,"summary":"Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.","last_synced_at":"2026-06-12T06:20:52.628605+00:00","page_url":"https://stenobird.com/podcast/breast-cancer-update-757579"},"episode":{"title":"ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy","slug":"er-positive-her2-positive-metastatic-breast-cancer-what-clinicians-want-to-know-about-first-line-and-maintenance-therapy","published_at":"2026-04-14T13:00:00+00:00","page_url":"https://stenobird.com/podcast/breast-cancer-update-757579/er-positive-her2-positive-metastatic-breast-cancer-what-clinicians-want-to-know-about-first-line-and-maintenance-therapy","show_page_url":"https://stenobird.com/podcast/breast-cancer-update-757579","url":"https://breast-oncology.captivate.fm/episode/5928-firstlinetherapyher2mbc26-1","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/33cd0fc5-0e6b-4490-abd3-2a17c92dfb98.mp3","summary":"Dr Virginia F Borges from the University of Colorado Anschutz Medical Campus in Aurora and Dr Ian E Krop from Yale Cancer Center in New Haven, Connecticut, review clinical research data and best practices guiding the selection of first-line and maintenance therapy for patients with ER-positive, HER2-positive metastatic breast cancer. CME information and select publications here .","meta_description":"Dr Virginia F Borges from the University of Colorado Anschutz Medical Campus in Aurora and Dr Ian E Krop from Yale Cancer Center in New Haven, Connecticut…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3479,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/er-positive-her2-positive-metastatic-breast-cancer-what-clinicians-want-to-know-about-first-line-and-maintenance-therapy/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/breast-cancer-update-757579/er-positive-her2-positive-metastatic-breast-cancer-what-clinicians-want-to-know-about-first-line-and-maintenance-therapy.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}